Skip to main content

CRISPR Therapeutics AG

CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001674416

In the last 90 days, CRISPR Therapeutics AG insiders filed 0 open-market purchases and 2 sales; 525 institutions reported holding it in 13F filings for Q2 2026, worth $4.16B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by CRISPR Therapeutics AG insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
2 insiders, $1.41M in total
Insiders trading
2
Net value
−$1.41M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for CRISPR Therapeutics AG, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for CRISPR Therapeutics AG
NameTitleLast reported holdingLast filingFilings, past year
Kasinger James R.General Counsel and Secretary94,784Sep 24, 20268
Behbahani AliDirector16,637Sep 21, 20263
Prasad RajuChief Financial Officer14,815Aug 11, 20268
Mahatme SandeshDirector–Jun 9, 20261
Fardis MariaDirector–Jun 9, 20261
George SimeonDirector1,730,179IndirectJun 9, 20261
Greene JohnDirector7,000Jun 9, 20261
High Katherine ADirector–Jun 9, 20261
Morrison BriggsDirector–Jun 9, 20261
Treco Douglas ADirector22,000Jun 9, 20261
Fleming Harold EdwardDirector–Jun 9, 20261
Rommel ChristianDirector–Jun 9, 20261
Patel NaimishChief Medical Officer19,357Jun 2, 20266
Kulkarni SamarthChief Executive Officer255,501Mar 24, 20269
Bruno JulianneChief Operating Officer10,544Mar 24, 20250
Morrow Phuong KhanhChief Medical Officer4,411Oct 17, 20230
Smith BrendanChief Financial Officer5,072Feb 22, 20230
Klein Lawrence OttoCBO & COO26,797Aug 18, 20220
Bolzon Bradley J PhDDirector148,831IndirectJun 10, 20220
Ho Tony WExecutive VP, Head of R&D52,364Dec 7, 20210
Tomsicek Michael JohnChief Financial Officer1,891Aug 10, 20210
Novak RodgerPresident573,007Jul 1, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 24, 2026 (view filing)5:35 PM ETSep 222 daysKasinger James R.General Counsel and SecretarySSale−10.4K$60.24−$626.5K−9.9%94.8K after10b5-1
Sep 21, 2026 (view filing)6:40 PM ETSep 174 daysBehbahani AliDirectorSSale−13.7K$57.09−$780.9K−45.1%16.6K after
Jun 1, 2026 (view filing)May 293 daysPatel NaimishChief Medical OfficerSSale−3.79K$55.62−$210.6K−16.4%19.4K after
Mar 24, 2026 (view filing)Mar 231 dayKasinger James R.General Counsel and SecretarySSale−3.18K$46.78−$148.9K−3.3%94.3K after
Mar 24, 2026 (view filing)Mar 231 dayKulkarni SamarthChief Executive OfficerSSale−10.0K$46.78−$468.7K−3.8%255.5K after
Mar 24, 2026 (view filing)Mar 231 dayPrasad RajuChief Financial OfficerSSale−3.71K$46.78−$173.5K−19.2%15.6K after
Mar 17, 2026 (view filing)Mar 161 dayPatel NaimishChief Medical OfficerSSale−3.15K$48.26−$152.0K−19.3%13.1K after
Mar 17, 2026 (view filing)Mar 161 dayPrasad RajuChief Financial OfficerSSale−9.87K$48.26−$476.3K−41.7%13.8K after2 lots
Mar 17, 2026 (view filing)Mar 161 dayKasinger James R.General Counsel and SecretarySSale−3.45K$48.26−$166.5K−3.6%91.2K after
Mar 17, 2026 (view filing)Mar 161 dayKulkarni SamarthChief Executive OfficerSSale−10.3K$48.26−$499.4K−4.0%245.8K after
Mar 12, 2026 (view filing)Mar 111 dayKasinger James R.General Counsel and SecretarySSale−2.80K$52.80−$147.8K−3.1%87.8K after
Mar 12, 2026 (view filing)Mar 111 dayKulkarni SamarthChief Executive OfficerSSale−9.80K$52.80−$517.3K−4.0%235.6K after
Feb 20, 2026 (view filing)Feb 191 dayKulkarni SamarthChief Executive OfficerSSale−6.97K$52.58−$366.3K−3.0%226.1K after
Feb 20, 2026 (view filing)Feb 191 dayKasinger James R.General Counsel and SecretarySSale−2.11K$52.58−$111.0K−2.4%85.1K after
Jan 27, 2026 (view filing)Apr 3, 2025299 daysLatePatel NaimishChief Medical OfficerPPurchase+1.51K$32.96+$49.7KNew position1.51K after
Jan 26, 2026 (view filing)Jan 224 daysPrasad RajuChief Financial OfficerSSale−35.0K$60.19−$2.10M−83.8%6.77K after10b5-1
Jan 22, 2026 (view filing)Jan 20-222 daysKulkarni SamarthChief Executive OfficerSSale−90.0K$57.40−$5.17M−40.1%134.2K after3 lots10b5-1
Jan 8, 2026 (view filing)Jan 62 daysPrasad RajuChief Financial OfficerSSale−29.7K$60.16−$1.79M−81.4%6.77K after3 lots10b5-1
Dec 23, 2025 (view filing)Dec 221 dayPrasad RajuChief Financial OfficerSSale−10.0K$55.95−$559.5K−59.6%6.77K after3 lots10b5-1
Oct 20, 2025 (view filing)Oct 173 daysKulkarni SamarthChief Executive OfficerSSale−50.9K$67.91−$3.46M−16.7%254.2K after
Oct 15, 2025 (view filing)Oct 141 dayKulkarni SamarthChief Executive OfficerSSale−4.24K$66.60−$282.5K−2.0%205.1K after
Oct 15, 2025 (view filing)Oct 141 dayKasinger James R.General Counsel and SecretarySSale−1.08K$66.60−$71.7K−1.3%83.4K after
Aug 19, 2025 (view filing)Aug 181 dayKulkarni SamarthChief Executive OfficerSSale−13.1K$58.15−$760.7K−5.9%207.0K after
Aug 8, 2025 (view filing)Aug 62 daysTreco Douglas ADirectorPPurchase+20.0K$57.03+$1.14M+1,000.0%22.0K after
Jul 17, 2025 (view filing)Jul 161 dayGeorge SimeonDirectorPPurchase+989.8K$52.03+$51.5M+133.7%1.73M after3 lots
May 30, 2025 (view filing)May 291 dayPatel NaimishChief Medical OfficerSSale−3.93K$35.94−$141.3K−39.3%6.07K after
Mar 24, 2025 (view filing)Mar 213 daysKulkarni SamarthChief Executive OfficerSSale−10.0K$41.23−$413.6K−4.9%195.1K after
Mar 24, 2025 (view filing)Mar 213 daysBruno JulianneChief Operating OfficerSSale−1.71K$41.23−$70.7K−14.0%10.5K after
Mar 24, 2025 (view filing)Mar 213 daysPrasad RajuChief Financial OfficerSSale−2.20K$41.23−$90.6K−11.6%16.8K after
Mar 24, 2025 (view filing)Mar 213 daysKasinger James R.General Counsel and SecretarySSale−3.19K$41.23−$131.3K−3.8%81.7K after
Mar 18, 2025 (view filing)Mar 171 dayPrasad RajuChief Financial OfficerSSale−3.76K$41.80−$157.3K−22.8%12.7K after
Mar 12, 2025 (view filing)Mar 11-121 dayKulkarni SamarthChief Executive OfficerSSale−14.4K$42.70−$616.3K−7.2%185.4K after2 lots
Mar 12, 2025 (view filing)Mar 11-121 dayKasinger James R.General Counsel and SecretarySSale−3.97K$42.67−$169.2K−4.8%78.7K after2 lots
Mar 12, 2025 (view filing)Mar 11-121 dayBruno JulianneChief Operating OfficerSSale−1.39K$42.54−$59.0K−14.0%8.51K after2 lots
Feb 28, 2025 (view filing)Feb 262 daysGreene JohnDirectorPPurchase+7.00K$44.85+$313.9KNew position7.00K after
Feb 21, 2025 (view filing)Feb 192 daysKulkarni SamarthChief Executive OfficerSSale−18.4K$55.21−$1.01M−9.7%171.6K after10b5-1
Feb 19, 2025 (view filing)Feb 19Same dayBruno JulianneChief Operating OfficerSSale−333$52.80−$17.6K−4.5%7.06K after
Feb 19, 2025 (view filing)Feb 18-191 dayKasinger James R.General Counsel and SecretarySSale−11.5K$53.67−$619.5K−13.4%74.9K after2 lots
Feb 19, 2025 (view filing)Feb 18-191 dayKulkarni SamarthChief Executive OfficerSSale−18.6K$54.21−$1.01M−8.9%190.0K after2 lots10b5-1
Dec 4, 2024 (view filing)Dec 22 daysKulkarni SamarthChief Executive OfficerSSale−15.0K$55.10−$826.5K−7.6%181.5K after10b5-1
Nov 13, 2024 (view filing)Nov 112 daysKulkarni SamarthChief Executive OfficerSSale−30.0K$55.62−$1.67M−13.2%196.5K after2 lots10b5-1
Oct 15, 2024 (view filing)Oct 141 dayKasinger James R.General Counsel and SecretarySSale−1.09K$46.28−$50.4K−1.7%62.6K after
Oct 15, 2024 (view filing)Oct 141 dayKulkarni SamarthChief Executive OfficerSSale−4.29K$46.28−$198.7K−1.9%226.5K after
Jun 24, 2024 (view filing)Jun 213 daysBruno JulianneChief Operating OfficerSSale−3.37K$56.09−$188.8K−33.3%6.75K after
Apr 17, 2024 (view filing)Apr 152 daysKulkarni SamarthChief Executive OfficerSSale−19.6K$59.91−$1.17M−8.6%208.1K after2 lots10b5-1
Mar 18, 2024 (view filing)Mar 153 daysPrasad RajuChief Financial OfficerSSale−3.52K$72.69−$256.2K−35.2%6.48K after
Mar 18, 2024 (view filing)Mar 153 daysKulkarni SamarthChief Executive OfficerSSale−20.0K$72.48−$1.45M−8.8%208.1K after2 lots10b5-1
Mar 12, 2024 (view filing)Mar 11-121 dayKasinger James R.General Counsel and SecretarySSale−3.95K$77.15−$304.5K−6.1%61.2K after2 lots
Mar 12, 2024 (view filing)Mar 11-121 dayKulkarni SamarthChief Executive OfficerSSale−14.4K$77.04−$1.11M−6.5%208.1K after2 lots
Feb 21, 2024 (view filing)Feb 201 dayKasinger James R.General Counsel and SecretarySSale−1.91K$79.67−$152.4K−3.2%57.4K after